1 (064 01)
Progesterone Capsule
Product Images NDC 73190-065
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 73190-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (065 01)
Chem Structure (Progesterone Capsules 1)
Figure 1 (Progesterone Capsules 2)
This is a description of a study on Estrogens treatment. It involves the use of Conjugated Estrogens plus Micronized Progesterone in a cyclical manner over a period of up to 36 months. The study tracked the number of patients remaining on the medication at 1, 24, and 36 months, with respective counts of 358, 312, 289, and 264 patients. The notation "n=total number of patients left at each time interval" further clarifies the data presented.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
